[ibd-display-video id=449433 width=50 float=left autostart=true] IBD's proprietary RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history reveals that the top-performing stocks tend to have an RS Rating north of 80 in the early stages of their moves.
Anthem is not currently near a potential buy zone. See if the stock goes on to build a base that could spark a new run.
Anthem posted 1% earnings growth last quarter, while sales growth came in at 4%.
Anthem holds the No. 8 rank among its peers in the Medical-Managed Care industry group. Centene ( CNC ), Cigna ( CI ) and UnitedHealth ( UNH ) are among the top 5 highly rated stocks within the group.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.